A systematic review found that bilateral salpingectomy is associated with roughly an 80% reduction in risk for the serous ...

For women, early signs of cervical cancer can feel harmless, a change in discharge, mild discomfort or simply feeling “off” ...

AIIMS Delhi doctors have successfully treated a colon cancer patient by removing a whopping 19.9 kg tumour from a 43-year-old ...

Women with certain genetic mutations are at extremely high risk of ovarian cancer. Now, some researchers are trying a new ...

Sofetabart mipitecan received FDA breakthrough therapy designation for platinum-resistant ovarian cancer after prior ...

Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough ...

Eli Lilly and Company (NYSE:LLY) is one of the best stocks to buy and hold for 20 years. On January 20, 2026, Guggenheim ...

Sofetabart mipitecan is an antibody-drug conjugate consisting of an Fc-silent, folate receptor alpha specific monoclonal antibody attached to an exatecan payload.

Eli Lilly and Co. has received the U.S. Food and Drug Administration’s breakthrough therapy designation for a drug in ...

Doctors at the All India Medical Sciences (AIIMS) Delhi on Friday announced a successful surgery where they removed a ...

Doctors at All India Institute of Medical Sciences (AIIMS) performed a rare, life-saving surgery to remove a nearly 20-kg tumour from a 43-year-old stage-4 colon cancer patient. The complex, two-stage ...

The FDA has granted breakthrough therapy designation (BTD) to sofetabart mipitecan (LY4170156) for the treatment of patients ...